Chemical Component Summary

Namenevanimibe
SynonymsN-({1-[4-(dimethylamino)phenyl]cyclopentyl}methyl)-N'-[2,6-di(propan-2-yl)phenyl]urea
Identifiers1-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]-3-[2,6-di(propan-2-yl)phenyl]urea
FormulaC27 H39 N3 O
Molecular Weight421.618
TypeNON-POLYMER
Isomeric SMILESCC(C)c1cccc(c1NC(=O)NCC2(CCCC2)c3ccc(cc3)N(C)C)C(C)C
InChIInChI=1S/C27H39N3O/c1-19(2)23-10-9-11-24(20(3)4)25(23)29-26(31)28-18-27(16-7-8-17-27)21-12-14-22(15-13-21)30(5)6/h9-15,19-20H,7-8,16-18H2,1-6H3,(H2,28,29,31)
InChIKeyPKKNCEXEVUFFFI-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count70
Chiral Atom Count0
Bond Count72
Aromatic Bond Count12

Drug Info: DrugBank

DrugBank IDDB16254 
NameNevanimibe
Groups investigational
DescriptionNevanimibe is under investigation in clinical trial NCT03053271 (A Study of ATR-101 for the Treatment of Endogenous Cushing's Syndrome).
Synonyms
  • Atr-101 free base
  • Nevanimibe
  • Nevanimibe hydrochloride
Categories
  • Amides
  • Benzene Derivatives
CAS number133825-80-6

Related Resource References

Resource NameReference
PubChem 131679
ChEMBL CHEMBL46423